EGFR expression is associated with decreased response from HER2 targeted therapeutics in the neoadjuvant setting in the NeoALTTO trial Meeting Abstract


Authors: Rimm, D. L.; Holmes, E.; Schalper, K.; Bradbury, I.; Zarrella, E.; Ellis, C.; Baselga, J.; Eidtmann, H.; Piccart, M.; Harbeck, N.; Pusztai, L.; Perez, E.
Abstract Title: EGFR expression is associated with decreased response from HER2 targeted therapeutics in the neoadjuvant setting in the NeoALTTO trial
Meeting Title: 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 73
Issue: 24 Suppl.
Meeting Dates: 2013 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2013-12-15
Language: English
ACCESSION: WOS:000209496900184
DOI: 10.1158/0008-5472.sabcs13-p1-08-09
PROVIDER: wos
Notes: Meeting Abstract: P1-08-09 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga